Expression of RPL15 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

RPL15 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 2020.61

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

2112.5

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	4879.9
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	4746.6
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	4442.0
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	4428.4
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	4371.3
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	4115.0
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	3620.4
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	3513.8
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	3466.8
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	3246.0
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	3109.0
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	3098.4
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	3040.3
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	3032.1
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	3020.0
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	3015.5
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	2987.2
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	2979.6
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	2950.1
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	2944.2
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	2909.3
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	2901.7
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	2797.4
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	2776.3
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	2745.1
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	2693.9
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	2657.2
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	2654.9
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	2639.8
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	2637.7
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	2603.4
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	2583.7
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	2581.0
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	2559.9
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	2527.1
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	2501.6
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	2495.6
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	2476.4
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	2470.0
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	2458.0
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	2448.3
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	2417.6
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	2396.7
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	2373.1
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	2364.7
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	2296.4
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	2296.2
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	2263.3
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	2260.7
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	2257.6
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	2241.2
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	2227.8
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	2227.6
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	2192.3
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	2136.8
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	2132.7
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	2132.2
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	2126.2
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	2125.9
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	2113.6
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	2068.1
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	2064.8
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	2059.8
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	2035.0
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	2028.0
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	2020.6
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	2000.6
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	1991.7
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	1979.2
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	1967.4
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	1966.8
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	1948.5
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	1929.9
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	1925.8
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	1911.1
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	1868.7
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	1849.7
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	1843.0
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	1820.4
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	1793.7
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	1787.2
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	1771.3
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	1760.8
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	1760.0
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	1758.3
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	1744.7
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	1720.1
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	1718.8
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	1711.4
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	1702.9
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	1702.1
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	1694.0
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	1693.2
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	1690.8
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	1683.2
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	1670.6
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	1665.6
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	1657.1
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	1639.6
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	1635.0
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	1627.0
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	1609.0
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	1608.2
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	1574.2
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	1548.1
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	1537.4
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	1522.3
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	1520.0
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	1515.3
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	1505.3
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	1503.2
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	1500.3
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	1481.8
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	1481.6
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	1476.2
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	1450.4
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	1440.2
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	1426.8
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	1411.1
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	1387.1
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	1383.5
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	1377.9
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	1375.2
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	1361.4
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	1352.2
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	1348.9
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	1345.4
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	1339.5
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	1324.6
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	1316.9
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	1304.1
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	1301.4
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	1288.3
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	1247.6
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	1243.9
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	1154.4
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	1101.4
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	1016.9
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	941.1
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	889.2
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	782.7
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

RPL15 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 403.87

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

447.5

Number of samples

Samples

Sample	Description	pTPM
AK213	N, NA, stage:NA, alive, 2010 days	834.2
AK142	N, NA, stage:NA, alive, 90 days	781.8
AK066	N, NA, stage:NA, alive, 960 days	759.2
AK124	N, NA, stage:NA, alive, 1920 days	732.8
AK051	N, NA, stage:NA, dead, 360 days	676.7
AK165	N, NA, stage:NA, alive, 360 days	645.6
AK199	N, NA, stage:NA, alive, 1860 days	628.1
AK049	N, NA, stage:NA, dead, 180 days	624.8
AK043	N, NA, stage:NA, alive, 660 days	590.5
AK139	N, NA, stage:NA, dead, 270 days	573.4
AK071	N, NA, stage:NA, dead, 540 days	543.6
AK173	N, NA, stage:NA, dead, 180 days	543.1
AK074	N, NA, stage:NA, alive, 300 days	538.6
AK002	N, NA, stage:NA, dead, 570 days	536.1
AK098	N, NA, stage:NA, dead, 660 days	513.6
AK183	N, NA, stage:NA, alive, 360 days	511.2
AK015	N, NA, stage:NA, alive, 720 days	499.7
AK178	N, NA, stage:NA, dead, 240 days	489.9
AK156	N, NA, stage:NA, dead, 330 days	481.9
AK231	N, NA, stage:NA, dead, 240 days	469.4
AK149	N, NA, stage:NA, dead, 420 days	464.3
AK055	N, NA, stage:NA, dead, 240 days	464.1
AK041	N, NA, stage:NA, alive, 810 days	460.4
AK188	N, NA, stage:NA, alive, 420 days	458.2
AK133	N, NA, stage:NA, dead, 360 days	444.2
AK158	N, NA, stage:NA, dead, 360 days	422.0
AK068	N, NA, stage:NA, alive, 360 days	420.5
AK134	N, NA, stage:NA, dead, 360 days	419.8
AK185	N, NA, stage:NA, alive, 330 days	405.3
AK100	N, NA, stage:NA, alive, 960 days	404.0
AK053	N, NA, stage:NA, dead, 300 days	403.7
AK072	N, NA, stage:NA, dead, 150 days	400.0
AK195	N, NA, stage:NA, dead, 390 days	392.8
AK236	N, NA, stage:NA, dead, 360 days	390.5
AK102	N, NA, stage:NA, alive, 1740 days	387.5
AK003	N, NA, stage:NA, dead, 600 days	383.3
AK088	N, NA, stage:NA, dead, 360 days	373.7
AK006	N, NA, stage:NA, dead, 360 days	373.1
AK030	N, NA, stage:NA, dead, 120 days	371.5
AK167	N, NA, stage:NA, dead, 180 days	369.8
AK117	N, NA, stage:NA, dead, 210 days	366.6
AK079	N, NA, stage:NA, dead, 210 days	362.3
AK153	N, NA, stage:NA, dead, 240 days	360.5
AK123	N, NA, stage:NA, dead, 180 days	359.4
AK216	N, NA, stage:NA, dead, 360 days	358.6
AK076	N, NA, stage:NA, alive, 660 days	357.1
AK089	N, NA, stage:NA, dead, 330 days	346.0
AK035	N, NA, stage:NA, dead, 210 days	339.9
AK205	N, NA, stage:NA, dead, 120 days	329.7
AK081	N, NA, stage:NA, dead, 180 days	328.3
AK227	N, NA, stage:NA, alive, 300 days	327.6
AK099	N, NA, stage:NA, dead, 420 days	298.9
AK091	N, NA, stage:NA, dead, 210 days	294.9
AK218	N, NA, stage:NA, dead, 180 days	292.9
AK103	N, NA, stage:NA, alive, 1320 days	286.1
AK226	N, NA, stage:NA, dead, 360 days	278.1
AK085	N, NA, stage:NA, alive, 660 days	250.9
AK005	N, NA, stage:NA, dead, 240 days	234.7
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0224390004	Tumor	1.0
CPT0206560003	Tumor	0.9
CPT0218330004	Tumor	0.7
CPT0225730003	Tumor	0.7
CPT0217710008	Tumor	0.6
CPT0217000004	Tumor	0.6
CPT0218690004	Tumor	0.6
CPT0190360004	Tumor	0.5
CPT0224540004	Tumor	0.5
CPT0162100003	Tumor	0.5
CPT0182580003	Tumor	0.5
CPT0218830004	Tumor	0.5
CPT0168380003	Tumor	0.5
CPT0228220003	Tumor	0.4
CPT0208980003	Tumor	0.4
CPT0079790003	Tumor	0.4
CPT0219080004	Tumor	0.4
CPT0093510003	Tumor	0.4
CPT0225760003	Tumor	0.4
CPT0127480003	Tumor	0.4
CPT0168080003	Tumor	0.4
CPT0189750004	Tumor	0.4
CPT0217100003	Tumor	0.4
CPT0217880003	Tumor	0.4
CPT0162020003	Tumor	0.3
CPT0002410011	Tumor	0.3
CPT0205780003	Tumor	0.3
CPT0217060003	Tumor	0.3
CPT0167640003	Tumor	0.3
CPT0168830003	Tumor	0.3
CPT0206670004	Tumor	0.3
CPT0171580008	Tumor	0.3
CPT0125510003	Tumor	0.3
CPT0161730003	Tumor	0.3
CPT0175060003	Tumor	0.2
CPT0167530003	Tumor	0.2
CPT0205450004	Tumor	0.2
CPT0078580003	Tumor	0.2
CPT0206780003	Tumor	0.2
CPT0205670004	Tumor	0.2
CPT0125570003	Tumor	0.2
CPT0206000004	Tumor	0.2
CPT0093360003	Tumor	0.2
CPT0167860004	Tumor	0.2
CPT0206230003	Tumor	0.1
CPT0182500003	Tumor	0.1
CPT0205570003	Tumor	0.1
CPT0216920008	Tumor	0.1
CPT0206880003	Tumor	0.1
CPT0127420003	Tumor	0.1
CPT0093590003	Tumor	0.1
CPT0087570003	Tumor	0.1
CPT0089150003	Tumor	0.0
CPT0168270003	Tumor	0.0
CPT0093450003	Tumor	0.0
CPT0168590003	Tumor	0.0
CPT0167750004	Tumor	0.0
CPT0205890003	Tumor	0.0
CPT0189570004	Tumor	0.0
CPT0168720003	Tumor	0.0
CPT0087950003	Tumor	0.0
CPT0186100003	Tumor	-0.1
CPT0125220003	Tumor	-0.1
CPT0064890003	Tumor	-0.1
CPT0218670003	Tumor	-0.1
CPT0064650003	Tumor	-0.1
CPT0093550003	Tumor	-0.1
CPT0207090003	Tumor	-0.1
CPT0221180003	Tumor	-0.1
CPT0189850004	Tumor	-0.1
CPT0224600003	Tumor	-0.1
CPT0206110003	Tumor	-0.1
CPT0217430008	Tumor	-0.1
CPT0196850003	Tumor	-0.1
CPT0123530003	Tumor	-0.2
CPT0199770003	Tumor	-0.2
CPT0217190003	Tumor	-0.2
CPT0209440003	Tumor	-0.2
CPT0087680003	Tumor	-0.2
CPT0182550003	Tumor	-0.2
CPT0207030003	Tumor	-0.3
CPT0201710003	Tumor	-0.3
CPT0189650004	Tumor	-0.3
CPT0189460003	Tumor	-0.3
CPT0167970003	Tumor	-0.3
CPT0087730003	Tumor	-0.3
CPT0071100003	Tumor	-0.3
CPT0204400003	Normal	-0.3
CPT0206330003	Tumor	-0.3
CPT0204340003	Normal	-0.3
CPT0092440003	Tumor	-0.3
CPT0204420003	Normal	-0.3
CPT0224330003	Tumor	-0.4
CPT0218890004	Tumor	-0.4
CPT0204360003	Normal	-0.4
CPT0168480003	Tumor	-0.4
CPT0104330003	Tumor	-0.4
CPT0204380003	Normal	-0.5
CPT0206450003	Tumor	-0.5
CPT0104220003	Tumor	-0.6
CPT0218960004	Tumor	-0.6
CPT0204370003	Normal	-0.7
CPT0189250003	Tumor	-0.7
CPT0204390003	Normal	-0.8
CPT0218770003	Tumor	-0.8
CPT0204410003	Normal	-0.8
CPT0162140003	Tumor	-0.8
CPT0204350003	Normal	-0.8
CPT0190240004	Tumor	-0.9
CPT0204330003	Normal	-1.0
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis